Abbas Malak, Gaye Amadou
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States.
Department of Integrative Genomics and Epidemiology, School of Graduate Studies, Meharry Medical School, Nashville, Tennessee, United States.
Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H603-H621. doi: 10.1152/ajpheart.00681.2024. Epub 2025 Feb 7.
This review comprehensively examines the diverse roles of noncoding RNAs (ncRNAs) in the pathogenesis and treatment of cardiovascular disease (CVD), focusing on microRNA (miRNA), long noncoding RNA (lncRNA), piwi-interacting RNA (piRNA), small-interfering RNA (siRNA), circular RNA (circRNA), and vesicle-associated RNAs. These ncRNAs are integral regulators of key cellular processes, including gene expression, inflammation, and fibrosis, and they hold great potential as both diagnostic biomarkers and therapeutic targets. The review highlights novel insights into how these RNA species, particularly miRNAs, lncRNAs, and piRNAs, contribute to various CVDs such as hypertension, atherosclerosis, and myocardial infarction. In addition, it explores the emerging role of extracellular vesicles (EVs) in intercellular communication and their therapeutic potential in cardiovascular health. The review underscores the need for continued research into ncRNAs and RNA-based therapies, with a focus on advancing delivery systems and expanding personalized medicine approaches to improve cardiovascular outcomes.
本综述全面研究了非编码RNA(ncRNA)在心血管疾病(CVD)发病机制和治疗中的多种作用,重点关注微小RNA(miRNA)、长链非编码RNA(lncRNA)、piwi相互作用RNA(piRNA)、小干扰RNA(siRNA)、环状RNA(circRNA)和囊泡相关RNA。这些ncRNA是关键细胞过程的重要调节因子,包括基因表达、炎症和纤维化,它们作为诊断生物标志物和治疗靶点都具有巨大潜力。该综述突出了关于这些RNA种类,特别是miRNA、lncRNA和piRNA如何促成各种心血管疾病(如高血压、动脉粥样硬化和心肌梗死)的新见解。此外,它还探讨了细胞外囊泡(EV)在细胞间通讯中的新兴作用及其在心血管健康方面的治疗潜力。该综述强调了对ncRNA和基于RNA的疗法持续进行研究的必要性,重点是推进递送系统和扩展个性化医疗方法以改善心血管疾病的治疗效果。